Therapeutic agents for the treatment of pulmonary arterial hypertension and other fibrosis-driven diseases, targeting a novel mechanism of action.
New Haven, CT
Investors 1
Date | Name | Website |
- | New Leaf V... | nlvpartner... |
Date | Name | Website |
- | New Leaf V... | nlvpartner... |